Podcasts | Accessible conversations on pharma's hot topics

Skip to main content

Tuesday 24 June 2025

BlueSky linkedin youtube rss

User account menu

Subscribe

Channels

Content type

Categories

Categories

Sort by

Order

Pharmaphorum menu first category

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
Spotlight on
Events

close

Channels

Content type

Categories

Categories

Sort by

Order

SECTION

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
White Papers
Events

Channels

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

SUB NAVIGATION

Live Coverage
Partner Content
About us
Work for us
Contribute
Contact us
Advertise

Newsletters and Deep Dive digital magazine

Sign up

BlueSky linkedin rss

Sign in

Market Access

pharmaphorum podcast Episode 187a

The changing landscape of drug clinical assessment: Tommy Br...

In a new pharmaphorum podcast, Tommy Bramley, SVP of market access and healthcare consulting at Cencora, discusses Joint Clinical Assessments.

R&D

Lady listening via ear pods to a podcast interview that features Melissa Sharman

Precision, speed, impact: Evolving mass spectrometry for med...

MOBILion's Melissa Sherman explores the evolving role of mass spectrometry in drug discovery, complex molecule analysis, and medical research.

Oncology

pharmaphorum podcast Episode 185a - Dr Stacy Lindborg

IMUNON at ASCO 2025: Changing the micro-tumour environment i...

Oncology

pharmaphorum podcast Episode 184a

Treating primary bone cancer: The potential of listeria-base...

In a new pharmaphorum podcast, Paul Romness, president and CEO of OS Therapies, discusses the company's work in osteosarcoma.

R&D

Citylabs 4.0

Sponsored

Where innovation meets collaboration: Live from Manchester’s...

Oncology

pharmaphorum podcast Episode 185a - Dr Stacy Lindborg

IMUNON at ASCO 2025: Changing the micro-tumour environment i...

Oncology

pharmaphorum podcast Episode 184a

Treating primary bone cancer: The potential of listeria-base...

In a new pharmaphorum podcast, Paul Romness, president and CEO of OS Therapies, discusses the company's work in osteosarcoma.

R&D

Citylabs 4.0

Sponsored

Where innovation meets collaboration: Live from Manchester’s...

Load more results

Sales & Marketing

Sales & Marketing

pharmaphorum podcast episode 107a

Looking to the future of UK medical device exports

In this second of our festive podcast series, the pharmaphorum podcast welcomed Brandon Medical CEO Keith Jackson and the Association of British HealthTech Industri

Sales & Marketing

pharmaphorum podcast episode 94a

Focussing on finding value in health sciences marketing

In this latest instalment of the pharmaphorum podcast, web editor Nicole Raleigh speaks with life sciences advisor Randall Hein, CEO of Heinsight LLC, and health sciences marketing expert K

Digital

Digital

pharmaphorum podcast Episode 176a - Andrew Stelzer, Unlearn.AI

AI in drug development: The real hurdle is implementation

Web editor Nicole Raleigh speaks with Andrew Stelzer, head of business development at Unlearn.AI, about effectively implementing AI.

Digital

pharmaphorum podcast Episode 175a - Bill Grambley, AllazoHealth

Patients as active consumers of care: AI-driven personalisat...

In a new podcast, web editor Nicole Raleigh speaks with Bill Grambley, CEO of AllazoHealth, for a conversation on leveraging AI for marketing.

Market Access

Market Access

pharmaphorum podcast Episode 187a

The changing landscape of drug clinical assessment: Tommy Br...

In a new pharmaphorum podcast, Tommy Bramley, SVP of market access and healthcare consulting at Cencora, discusses Joint Clinical Assessments.

Market Access

pharmaphorum podcast Episode 179a - Cen Zorlular, Er-Kim Pharmaceuticals

EAPs: Market access outside of the US and Western Europe

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Cem Zorlular, CEO of Er-Kim Pharmaceuticals about early access programmes.

Editor's Picks

Gilead's twice-yearly PrEP drug is cleared by FDA

Could a Novo error set up early GLP-1 generics in Canada?

23andMe fined £2.31m over UK users' genetic data breach

FDA blocks trials that send US cells to 'hostile' countries

UK regulator overhauls medical device regulation

Newsletters and Deep Dive
digital magazine

Get in-depth news, opinions, and features on pharma and healthcare sent straight to your inbox

Oncology

Oncology

pharmaphorum podcast Episode 185a - Dr Stacy Lindborg

IMUNON at ASCO 2025: Changing the micro-tumour environment i...

Oncology

pharmaphorum podcast Episode 184a

Treating primary bone cancer: The potential of listeria-base...

In a new pharmaphorum podcast, Paul Romness, president and CEO of OS Therapies, discusses the company's work in osteosarcoma.

Oncology

lady walking and listening to audio

Servier’s ASCO 2025 data: Advancing IDH-mutated cancer treat...

At ASCO 2025, Servier’s Becky Martin discusses IDH-mutated cancers, including key insights on Tibsovo & Voranigo, and the implications for patients.

Patients

Patients

pharmaphorum podcast Episode 180a - Rebecca Catterick

The need for a science-first mindset: The vaccine landscape ...

In a new pharmaphorum podcast, Rebecca Catterick, previously at Sanofi, discusses the decline in vaccination rates.

Patients

pharmaphorum podcast Episode 177a - Rob Abbott, ISPOR

The ins and outs of HEOR – A lever for global health

Web editor Nicole Raleigh speaks with Rob Abbott, CEO and executive director of ISPOR, about the ins and outs and trends of HEOR.

Patients

pharmaphorum Episode 172a - David Gillen, Norgine

Prevention for a healthier, more productive society

During Anthropy 2025: Rebooting Britain, web editor Nicole Raleigh spoke with David Gillen, chief medical officer at Norgine.

R&D

R&D

Lady listening via ear pods to a podcast interview that features Melissa Sharman

Precision, speed, impact: Evolving mass spectrometry for med...

MOBILion's Melissa Sherman explores the evolving role of mass spectrometry in drug discovery, complex molecule analysis, and medical research.

R&D

Citylabs 4.0

Sponsored

Where innovation meets collaboration: Live from Manchester’s...

R&D

pharmaphorum podcast Episode 181a - Liz Beatty, Inato

Bringing patients to research centres: Using AI to bring eff...

Editor's Picks

Gilead's twice-yearly PrEP drug is cleared by FDA

Could a Novo error set up early GLP-1 generics in Canada?

23andMe fined £2.31m over UK users' genetic data breach

FDA blocks trials that send US cells to 'hostile' countries

UK regulator overhauls medical device regulation

Market Access

pharmaphorum podcast Episode 187a

The changing landscape of drug clinical assessment: Tommy Br...

In a new pharmaphorum podcast, Tommy Bramley, SVP of market access and healthcare consulting at Cencora, discusses Joint Clinical Assessments.

Market Access

pharmaphorum podcast Episode 178a - Sandra Anderson and Chris Williams, Cencora

The value of a partner, globally and locally

A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face

Pharmaphorum Menu

Digital
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Market Access
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Oncology
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Patients
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
R&D
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Sales & Marketing
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Spotlight on

Sign up for email newsletters and Deep Dive

Subscribe

rss youtube linkedin BlueSky

About us Advertising Contact us

Contribute Cookie Policy Privacy Policy

Terms & Conditions Work for us

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2025, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2025, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company